Skip to main content
Journal cover image

Further evidence for the use of aspirin in COVID-19.

Publication ,  Journal Article
Tantry, US; Bliden, KP; Gurbel, PA
Published in: Int J Cardiol
January 1, 2022

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

Int J Cardiol

DOI

EISSN

1874-1754

Publication Date

January 1, 2022

Volume

346

Start / End Page

107 / 108

Location

Netherlands

Related Subject Headings

  • SARS-CoV-2
  • Humans
  • Cardiovascular System & Hematology
  • COVID-19
  • Aspirin
  • 3201 Cardiovascular medicine and haematology
  • 1117 Public Health and Health Services
  • 1102 Cardiorespiratory Medicine and Haematology
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Tantry, U. S., Bliden, K. P., & Gurbel, P. A. (2022). Further evidence for the use of aspirin in COVID-19. Int J Cardiol, 346, 107–108. https://doi.org/10.1016/j.ijcard.2021.11.021
Tantry, Udaya S., Kevin P. Bliden, and Paul A. Gurbel. “Further evidence for the use of aspirin in COVID-19.Int J Cardiol 346 (January 1, 2022): 107–8. https://doi.org/10.1016/j.ijcard.2021.11.021.
Tantry US, Bliden KP, Gurbel PA. Further evidence for the use of aspirin in COVID-19. Int J Cardiol. 2022 Jan 1;346:107–8.
Tantry, Udaya S., et al. “Further evidence for the use of aspirin in COVID-19.Int J Cardiol, vol. 346, Jan. 2022, pp. 107–08. Pubmed, doi:10.1016/j.ijcard.2021.11.021.
Tantry US, Bliden KP, Gurbel PA. Further evidence for the use of aspirin in COVID-19. Int J Cardiol. 2022 Jan 1;346:107–108.
Journal cover image

Published In

Int J Cardiol

DOI

EISSN

1874-1754

Publication Date

January 1, 2022

Volume

346

Start / End Page

107 / 108

Location

Netherlands

Related Subject Headings

  • SARS-CoV-2
  • Humans
  • Cardiovascular System & Hematology
  • COVID-19
  • Aspirin
  • 3201 Cardiovascular medicine and haematology
  • 1117 Public Health and Health Services
  • 1102 Cardiorespiratory Medicine and Haematology